{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fcua.simplecast.com%2Fepisodes%2Fcanadian-expert-discussion-on-optimizing-rcc-treatment-ouRhSkuU","width":444,"version":"1.0","type":"rich","title":"Canadian Expert discussion on optimizing RCC treatment","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/40e324e4-37cd-499e-8e40-fe60892c64a7/389103f6-e311-44b0-ba7f-29459207a502/cua-crest-logo-2019-final.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/649c4a06-58be-4ece-87f8-78c9511ae355\" height=\"200\" width=\"100%\" title=\"Canadian Expert discussion on optimizing RCC treatment\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this podcast, Dr. Aly-Khan Lalani and Dr. Toni Choueiri reflect on the latest advancements in systemic therapy for patients with RCC, summarize the clinical efficacy of newly available IO/TKI treatment options for Canadian patients with RCC. They also discuss treatment selection and management considerations for IO/TKI treatment regimens in the Canadian context.\n"}